Actively Recruiting
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
Led by Ruijin Hospital · Updated on 2023-06-15
800
Participants Needed
1
Research Sites
391 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The great harm of pancreatic diseases and the unknown etiology and pathogenesis make it difficult to intervene in most early cases in time. Previous studies by scholars and applicants at home and abroad have shown that the microflora in pancreatic tissue is closely related to chronic pancreatitis and pancreatic cancer. However, the research on the mechanism of microbial diversity in pancreatic tissue and the occurrence and development of various pancreatic diseases has not been reported. Based on the previous research, this subject continues to take various pancreatic diseases as the research object based on the database of pancreatic center and pathology department of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, To explore the characteristics of microbial flora in pancreas in different pancreatic diseases and its mechanism of influence on disease microenvironment. Select specific microbial flora or targets in the pancreas for various pancreatic diseases, so as to provide new theoretical basis and practical guidance for the early diagnosis and treatment of pancreatic diseases.
CONDITIONS
Official Title
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 5 years or older and 85 years or younger
- Patient must have undergone routine surgery with postoperative pathology confirming pancreatic cancer or other pancreatic diseases
- No use of antibiotics or yogurt containing probiotics for three months before surgery
- No serious damage to heart, liver, or kidney function
You will not qualify if you...
- Use of antibiotics or yogurt containing probiotics within three months
- Evidence of sensory or motor neuropathy
- Diagnosed cardiovascular disease, severe associated disease, or active infection including HIV
- History of other cancers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital
Shanghai, China, 200025
Actively Recruiting
Research Team
W
Wei Wang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here